Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

Featured Interview: CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY)

  CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY), joins the Show to discuss recent Phase 3 trials and results of PRO140 monotherapy for the chronic suppression of HIV.

 

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Close Menu